drugset / Trial / NCT05468957
Comparing Perclose to Statseal in Conjunction With Perclose in Femoral 6 French Arteriotomy Closure
Withdrawn
University of California, Los Angeles
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this clinical study is to compare how well two different devices for achieving hemostasis perform in patients undergoing transfemoral procedures with 6 French Access. Both devices are approved by the FDA for this use, and have already been used by clinicians on patients undergoing transfemoral procedures. It is believed that the use of both devices in combination compared to the Perclose alone will shorten the time that it takes to 'seal' the artery, resulting in a shorter period of time that patients would need to lay flat.
Timeline
- Start
- 2022-08-01
- Primary completion
- 2025-07-31
- Completion
- 2025-07-31
Outcome
Outcome not reported
Stopped: “Initiating PI left our institution.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Statseal | Unknown | — | Topical |